Long-term serial changes in platelet activation indices following sirolimus elution and bare metal stent implantation in patients with stable coronary artery disease

Kuchulakanti, 2006, Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents, Circulation, 113, 1108, 10.1161/CIRCULATIONAHA.105.600155 Iakovou, 2005, Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents, JAMA, 293, 2126, 10.1001/jama.293.17.2126 Dangas, 2004, Predictors of and outcomes of early thrombosis following balloon angioplasty versus primary stenting in acute myocardial infarction and usefulness of abciximab (the CADILLAC trial), Am J Cardiol, 94, 983, 10.1016/j.amjcard.2004.06.050 Babinska, 1998, Enhancement of human platelet aggregation and secretion induced by rapamycin, Nephrol Dial Transplant, 13, 3153, 10.1093/ndt/13.12.3153 Inoue, 2000, Comparison of activation process of platelets and neutrophils after coronary stent implantation versus balloon angioplasty for stable angina pectoris, Am J Cardiol, 86, 1057, 10.1016/S0002-9149(00)01159-0 Gasperetti, 1993, Platelet activation during coronary angioplasty in humans, Circulation, 88, 2728, 10.1161/01.CIR.88.6.2728 Vaitkus, 1995, Characterization of platelet activation and thrombin generation accompanying percutaneous transluminal coronary angioplasty, Coron Artery Dis, 6, 587 Schwartz, 1993, Coronary restenosis: prospects for solution and new perspectives from a porcine model, Mayo Clin Proc, 68, 54, 10.1016/S0025-6196(12)60019-6 Roubin, 1992, Intracoronary stenting for acute or threatened closure complicating percutaneous transluminal coronary angioplasty, Circulation, 85, 916, 10.1161/01.CIR.85.3.916 Strauss, 1992, Quantitative angiographic follow-up of the coronary wall stent in native vessels and bypass grafts (European experience—March 1986—March 1990), Am J Cardiol, 69, 475, 10.1016/0002-9149(92)90989-C Agrawal, 1994, Predictors of thrombotic complications after placement of the flexible coil stent, Am J Cardiol, 73, 1216, 10.1016/0002-9149(94)90186-4 Nath, 1993, Thrombosis of a flexible coil coronary stent: frequency predictors and clinical outcome, J Am Coll Cardiol, 21, 622, 10.1016/0735-1097(93)90093-G Tada, 2013, Risk of stent thrombosis among bare-metal stents, first-generation drug-eluting stents, and second-generation drug-eluting stents: results from a registry of 18,334 patients, JACC Cardiovasc Interv, 6, 1267, 10.1016/j.jcin.2013.06.015 Babapulle, 2004, A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents, Lancet, 364, 583, 10.1016/S0140-6736(04)16850-5 Tepe, 2002, Thrombogenicity of various endovascular stent types: an in vitro evaluation, J Vasc Interv Radiol, 13, 1029, 10.1016/S1051-0443(07)61868-5 Walter, 2010, Thrombogenicity of sirolimus-eluting stents and bare metal stents: evaluation in the early phase after stent implantation, In Vivo, 24, 635 Virchow, 1856, 219 Lip, 1997, Von Willebrand factor: a marker of endothelial dysfunction in vascular disorders?, Cardiovasc Res, 34, 255, 10.1016/S0008-6363(97)00039-4 Yazdani, 1997, Percutaneous interventions alter the hemostatic profile of patients with unstable angina, J Am Coll Cardiol, 30, 1284, 10.1016/S0735-1097(97)00275-1 Gibson, 2006, Comparison of effects of bare metal versus drug-eluting stent implantation on biomarker levels following percutaneous coronary intervention for non-ST-elevation acute coronary syndrome, Am J Cardiol, 97, 1473, 10.1016/j.amjcard.2005.12.037 Nührenberg, 2005, Rapamycin attenuates vascular wall inflammation and progenitor cell promoters after angioplasty, FASEB J, 19, 246, 10.1096/fj.04-2431fje Jaumdally, 2007, Platelet activation in coronary artery disease. Intracardiac vs peripheral venous levels and the effects of angioplasty, Chest, 132, 1532, 10.1378/chest.07-0389